Drivers of biodiagnostic development

David A. Giljohann, Chad A. Mirkin

Research output: Contribution to journalReview articlepeer-review

591 Scopus citations


The promise of point-of-care medical diagnostics ĝ€" tests that can be carried out at the site of patient care ĝ€" is enormous, bringing the benefits of fast and reliable testing and allowing rapid decisions on the course of treatment to be made. To this end, much innovation is occurring in technologies for use in biodiagnostic tests. Assays based on nanomaterials, for example, are now beginning to make the transition from the laboratory to the clinic. But the potential for such assays to become part of routine medical testing depends on many scientific factors, including sensitivity, selectivity and versatility, as well as technological, financial and policy factors.

Original languageEnglish (US)
Pages (from-to)461-464
Number of pages4
Issue number7272
StatePublished - Nov 26 2009

ASJC Scopus subject areas

  • General


Dive into the research topics of 'Drivers of biodiagnostic development'. Together they form a unique fingerprint.

Cite this